{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-026356","form_type":"8-K","ticker":"BCDA","cik":"0000925741","company_name":"BioCardia, Inc.","filed_at":"2025-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.722287+00:00","generated_at":"2026-05-17T14:10:47.111345+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BioCardia and CART-Tech enter exclusive pact for Heart3D Fusion Imaging","bullets":["Exclusive development/commercialization agreement for Heart3D Fusion Imaging, enhancing 2D x-rays with 3D anatomical models.","BioCardia gets exclusive global rights for biotherapeutic delivery and US rights for cardiac biopsy distribution.","Management estimates $100M annual revenue potential from Heart3D if single large-market biologic becomes standard of care.","Cross-licensing: BioCardia licenses CART-Tech IP for biotherapeutic intervention; CART-Tech licenses BioCardia IP for CRT.","Heart3D initially sold as research tool for preclinical studies, later for clinical practice."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-026356","json":"https://secwatch.observer/filing/0001437749-25-026356.json","markdown":"https://secwatch.observer/filing/0001437749-25-026356.md","text":"https://secwatch.observer/filing/0001437749-25-026356.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/925741/000143774925026356/0001437749-25-026356-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/925741/000143774925026356/bcda20250812_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T14:10:47.111345+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}